KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesR&D In ProcessReceivables - NetReceivables - OtherShares Repurchased
Ratios

Eli Lilly (LLY) Shares Repurchased (2016 - 2025)

Eli Lilly (LLY) has disclosed Shares Repurchased for 14 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Repurchased fell 26.59% year-over-year to $1.5 billion, compared with a TTM value of $4.1 billion through Dec 2025, up 64.32%, and an annual FY2025 reading of $4.1 billion, up 64.32% over the prior year.
  • Shares Repurchased was $1.5 billion for Q4 2025 at Eli Lilly, up from $708.1 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $2.1 billion in Q4 2024 and bottomed at $446.1 million in Q3 2024.
  • Average Shares Repurchased over 5 years is $1.0 billion, with a median of $750.0 million recorded in 2021.
  • The sharpest move saw Shares Repurchased tumbled 50.0% in 2023, then skyrocketed 58.73% in 2025.
  • Year by year, Shares Repurchased stood at $750.0 million in 2021, then skyrocketed by 100.0% to $1.5 billion in 2022, then crashed by 50.0% to $750.0 million in 2023, then soared by 173.85% to $2.1 billion in 2024, then decreased by 26.59% to $1.5 billion in 2025.
  • Business Quant data shows Shares Repurchased for LLY at $1.5 billion in Q4 2025, $708.1 million in Q3 2025, and $692.2 million in Q2 2025.